Cholesterol esterification reduces the neurotoxicity of prions

Neuropharmacology

Volumn 54, Issue 8, 2008, Pages 1247-1253

  Bate, Clive ^a   Tayebi, Mourad ^a   Williams, Alun ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Acyl coenzyme A:cholesterol acyltransferase; Cholesterol; Cholesterol esters; Neurotoxicity; Phospholipase A2; Prion; Prostaglandins

Indexed keywords

ACYLTRANSFERASE; CASPASE 3; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; FR 179254; MEVINOLIN; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN E2; SQUALESTATIN; TMP 153; YIC C 8 434; YICC 8 434;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL SURVIVAL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; INFECTION; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL;

CASPASE 3; CELL LINE; CHOLESTEROL; CINNAMATES; DINOPROSTONE; ENZYME INHIBITORS; HUMANS; NEUROPROTECTIVE AGENTS; PHENYLUREA COMPOUNDS; PHOSPHOLIPASES A2; PIPERAZINES; PRION DISEASES; PRIONS; STEROL O-ACYLTRANSFERASE;

EID: 43949131039     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.04.002     Document Type: Article

References (47)

1. Bate C., Rutherford S., Gravenor M., Reid S., and Williams A. Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro. Neuroreport 13 (2002) 1933-1938
2. Bate C., Salmona M., Diomede L., and Williams A. Squalestatin cures prion-infected neurones and protects against prion neurotoxicity. J. Biol. Chem. 279 (2004) 14983-14990
3. Bate C., Salmona M., and Williams A. The role of platelet activating factor in prion and amyloid-β neurotoxicity. Neuroreport 15 (2004) 509-513
4. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., and Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379 (1996) 339-343
5. Bueler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., and Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 73 (1993) 1339-1347
6. Chang T.Y., Chang C.C.Y., and Cheng D. Acyl-coenzyme A:cholesterol acyltransferase. Annual Rev. Biochem. 66 (1997) 613-638
7. Cooper D.M.F., and Crossthwaite A.J. Higher-order organization and regulation of adenylyl cyclases. Trends Pharmacol. Sci. 27 (2006) 426-431
8. Fai Mok S.W., Thelen K.M., Riemer C., Bamme T., Gultner S., Lutjohann D., and Baier M. Simvastatin prolongs survival times in prion infections of the central nervous system. Biochem. Biophys. Res. Comm. 348 (2006) 697-702
9. Gorodinsky A., and Harris D.A. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J. Cell Biol. 129 (1995) 619-627
10. Graziani A., Bricko V., Carmignani M., Graier W.F., and Groschner K. Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A(2)-dependent EDHF formation. Cardiovasc. Res. 64 (2004) 234-242
11. Grimmer S., Ying M., Walchli S., van Deurs B., and Sandvig K. Golgi vesiculation induced by cholesterol occurs by a dynamin- and cPLA2-dependent mechanism. Traffic 6 (2005) 144-156
12. Hutter-Paier B., Huttunen H.J., Puglielli L., Eckman C.B., Kim D.Y., Hofmeister A., Moir R.D., Domnitz S.B., Frosch M.P., Windisch M., and Kovacs D.M. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron 44 (2004) 227-238
13. Jeffrey M., Halliday W.G., Bell J., Johnston A.R., MacLeod N.K., Ingham C., Sayers A.R., Brown D.A., and Fraser J.R. Synapse loss associated with abnormal PrP precedes neuronal degeneration in the scrapie-infected murine hippocampus. Neuropathol. Appl. Neurobiol. 26 (2000) 41-54
14. Kaneko K., Uchida K., Kobayashi T., Miura K., Tanokura K., Hoshino K., Kato I., Onoue M., and Yokokura T. Sex-dependent toxicity of a novel acyl-CoA:cholesterol acyltransferase inhibitor, YIC-C8-434, in relation to sex-specific forms of cytochrome P450 in rats. Toxicol. Sci. 64 (2001) 259-268
15. Kellner-Weibel G., Jerome W.G., Small D.M., Warner G.J., Stoltenborg J.K., Kearney M.A., Corjay M.H., Phillips M.C., and Rothblat G.H. Effects of intracellular free cholesterol accumulation on macrophage viability: a model for foam cell death. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 423-431
16. Kempster S., Bate C., and Williams A. Simvastatin treatment prolongs the survival of scrapie-infected mice. Neuroreport 18 (2007) 479-482
17. Koh C.H., Peng Z.F., Ou K., Melendez A., Manikandan J., Qi R.Z., and Cheung N.S. Neuronal apoptosis mediated by inhibition of intracellular cholesterol transport: microarray and proteomics analyses in cultured murine cortical neurons. J. Cell. Physiol. 211 (2007) 63-87
18. Li S., Couet J., and Lisanti M.P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J. Biol. Chem. 271 (1996) 29182-29190
19. Ma J., Wollmann R., and Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 298 (2002) 1781-1785
20. Maeda Y., Tashima Y., Houjou T., Fujita M., Yoko-o T., Jigami Y., Taguchi R., and Kinoshita T. Fatty acid remodeling of GPI-anchored proteins is required for their raft association. Mol. Biol. Cell 18 (2007) 1497-1506
21. Mallucci G., Dickinson A., Linehan J., Klohn P.C., Brandner S., and Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302 (2003) 871-874
22. Mann R.K., and Beachy P.A. Cholesterol modification of proteins. Biochim. Biophys. Acta (BBA) 1529 (2000) 188-202
23. Minghetti L., Cardone F., Greco A., Puopolo M., Levi G., Green A.J., Knight R., and Pocchiari M. Increased CSF levels of prostaglandin E(2) in variant Creutzfeldt-Jakob disease. Neurology 58 (2002) 127-129
24. Minghetti L., Greco A., Cardone F., Puopolo M., Ladogana A., Almonti S., Cunningham C., Perry V.H., Pocchiari M., and Levi G. Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies. J. Neuropathol. Exp. Neurol. 59 (2000) 866-871
25. Muller W.E., Ushijima H., Schroder H.C., Forrest J.M., Schatton W.F., Rytik P.G., and Heffner-Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur. J. Pharmacol. 246 (1993) 261-267
26. Neuhaus O., Stuve O., Zamvil S.S., and Hartung H.P. Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles. CNS Drugs 19 (2005) 833-841
27. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12 (2001) 685-698
28. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., and Cohen F.E. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 10962-10966
29. Pike L.J. Lipid rafts: heterogeneity on the high seas. Biochem. J. 378 (2004) 281-292
30. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13363-13383
31. Puglielli L., Konopka G., Pack-Chung E., Ingano L.A., Berezovska O., Hyman B.T., Chang T.Y., Tanzi R.E., and Kovacs D.M. Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat. Cell Biol. 3 (2001) 905-912
32. Puglielli L., Tanzi R.E., and Kovacs D.M. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6 (2003) 345-351
33. Salmona M., Morbin M., Massignan T., Colombo L., Mazzoleni G., Capobianco R., Diomede L., Thaler F., Mollica L., Musco G., Kourie J.J., Bugiani O., Sharma D., Inouye H., Kirschner D.A., Forloni G., and Tagliavini F. Structural properties of Gerstmann-Straussler-Scheinker disease amyloid protein. J. Biol. Chem. 278 (2003) 48146-48153
34. Sathishkumar K., Murthy S.N., and Uppu R.M. Cytotoxic effects of oxysterols produced during ozonolysis of cholesterol in murine GT1-7 hypothalamic neurons. Free Rad. Res. 41 (2007) 82-88
35. Schatzl H.M., Laszlo L., Holtzman D.M., Tatzelt J., DeArmond S.J., Weiner R.I., Mobley W.C., and Prusiner S.B. A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J. Virol. 71 (1997) 8821-8831
36. Schroeder F., Gallegos A.M., Atshaves B.P., Storey S.M., McIntosh A.L., Petrescu A.D., Huang H., Starodub O., Chao H., Yang H., Frolov A., and Kier A.B. Recent advances in membrane microdomains: rafts, caveolae, and intracellular cholesterol trafficking. Exp. Biol. Med. 226 (2001) 873-890
37. Schroeder R., London E., and Brown D. Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc. Natl. Acad. Sci. U.S.A 91 (1994) 12130-12134
38. Silveira J.R., Raymond G.J., Hughson A.G., Race R.E., Sim V.L., Hayes S.F., and Caughey B. The most infectious prion protein particles. Nature 437 (2005) 257-261
39. Simons K., and Ikonen E. How cells handle cholesterol. Science 290 (2000) 1721-1726
40. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
41. Simons M., Keller P., Dichgans J., and Schulz J.B. Cholesterol and Alzheimer's disease: is there a link?. Neurology 57 (2001) 1089-1093
42. Stahl N., Baldwin M.A., Burlingame A.L., and Prusiner S.B. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry 29 (1990) 8879-8884
43. Stahl N., Borchelt D.R., Hsiao K., and Prusiner S.B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51 (1987) 229-240
44. Sugiyama Y., Ishikawa E., Odaka H., Miki N., Tawada H., and Ikeda H. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Atherosclerosis 113 (1995) 71-78
45. Tanaka A., Terasawa T., Hagihara H., Kinoshita T., Sakuma Y., Ishibe N., Sawada M., Takasugi H., and Tanaka H. Synthesis, X-ray crystal structure, and biological activity of FR186054, a novel, potent, orally active inhibitor of acyl-CoA:cholesterol O-acyltransferase (ACAT) bearing a pyrazole ring. Bioorg. Med. Chem. Lett. 8 (1998) 81-86
46. Williams A., Lucassen P.J., Ritchie D., and Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144 (1997) 433-438
47. Williams A., Van Dam A.M., Ritchie D., Eikelenboom P., and Fraser H. Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations. Brain Res. 754 (1997) 171-180